Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shan Dong Kexing Bioproducts Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688136'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.14 Med: 0.29 Max: 1.21
Current: 1.21
During the past 9 years, Shan Dong Kexing Bioproducts Co's highest Yield on Cost was 1.21. The lowest was 0.14. And the median was 0.29.
SHSE:688136's 5-Year Yield-on-Cost % is ranked worse than 58% of 150
companies
in the Biotechnology industry
Industry Median: 1.67
vs SHSE:688136: 1.21
Shan Dong Kexing Bioproducts Co (SHSE:688136) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shan Dong Kexing Bioproducts Co 5-Year Yield-on-Cost % Related Terms
SHSE:688136 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shan Dong Kexing Bioproducts Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shan Dong Kexing Bioproducts Co's 5-Year Yield-on-Cost % falls into.
Shan Dong Kexing Bioproducts Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a 5-Year Yield-on-Cost % of 1.21 as of Aug. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. This is 317% above median its historical median of 0.29. Over the past decade, Shan Dong Kexing Bioproducts Co's 5-Year Yield-on-Cost % has ranged from 0.14 to 1.21. According to the industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #87 out of 150 companies in the Biotechnology industry, placing it in the top 58%.
Is Shan Dong Kexing Bioproducts Co's 5-Year Yield-on-Cost % too high?
Shan Dong Kexing Bioproducts Co's current 5-Year Yield-on-Cost % of 1.21 is 317% above median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 1.21. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.67. Shan Dong Kexing Bioproducts Co's value of 1.21 is 27.5% below this industry median. Based on the distribution chart, Shan Dong Kexing Bioproducts Co ranks #87 out of 150 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #87 out of 150 companies for 5-Year Yield-on-Cost %. This places Shan Dong Kexing Bioproducts Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.67. Shan Dong Kexing Bioproducts Co's value of 1.21 is 27.5% below this benchmark. Historically, Shan Dong Kexing Bioproducts Co's own 5-Year Yield-on-Cost % has ranged from 0.14 to 1.21 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 1.67, Shan Dong Kexing Bioproducts Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.67, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shan Dong Kexing Bioproducts Co's current 5-Year Yield-on-Cost % of 1.21 is 27.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shan Dong Kexing Bioproducts Co's current 5-Year Yield-on-Cost % is 1.21, which is 317% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.36, compared to a current price of ¥20.29 — trading 16.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.21, which is 317% above median its 10-year median of 0.29 and 27.5% below the Biotechnology industry median of 1.67. Shan Dong Kexing Bioproducts Co's overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current 5-Year Yield-on-Cost % is 1.21 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued.
The current stock price of ¥20.29 is trading 16.7% below its estimated GF Value™ of ¥24.36.
GuruFocus considers Shan Dong Kexing Bioproducts Co to be Modestly Undervalued.
Key valuation signals for SHSE:688136:
5-Year Yield-on-Cost %: 1.21 (317% above median its 10-year median of 0.29)
GF Value™: ¥24.36 vs. price of ¥20.29 (16.7% below fair value)
Industry Position: 27.5% below the Biotechnology median (#87 of 150)
No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
46GF Score
Get the complete analysis for SHSE:688136
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688136 has been successfully added to your 
